Dr. Payam Saadat, MD

Dr. Saadat practices at Skin and Beauty Center Inc in Burbank, California.

Dr. Saadat's NPI, 1740487925, was assigned on June 29, 2007. Dr. Saadat graduated from Keck School of Medicine of USC in 2004. Dr. Saadat holds California license A93040.

Dr. Saadat's primary practice is Skin and Beauty Center Inc, at 2720 W Magnolia Blvd, Burbank, CA 91505 in Los Angeles County. The practice phone is (818) 842-8000.

Dr. Saadat's primary practice is Skin and Beauty Center Inc in Burbank, California. The medical group on file is Skin & Beauty Center (SBC Dermatology). Dmand AI also links Dr. Saadat to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saadat practices. Vendor and product names are available with a free account.

Dermatology is Dr. Saadat's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Saadat is board certified in dermatology by the American Board of Dermatology. Dr. Saadat is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Saadat treats.

CMS data shows 6,492 Medicare services from Dr. Saadat across 40 procedure codes in 2024, for 1,141 Medicare patients. Medicare paid $873,200 for them. Every service was in an office.

CMS counts 1,141 Medicare patients who saw Dr. Saadat in 2024. The largest group is 65 to 74, with 532 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Saadat's median patient age at 60, with 54% women.

In 2024, Dr. Saadat wrote 1,103 Medicare Part D claims for 517 patients. 93% of them were for generic drugs. CMS names the drug for 956 of them, across 16 drugs with 11 or more claims each, at $240,124 in total drug cost. In 2023, CMS named 813 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Saadat for performance year 2024, reported as part of a group. Dr. Saadat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 482 procedures of skin biopsy by Dr. Saadat, more than 95% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Saadat, published from 2007 to 2012. The most frequent topics are Skin Neoplasms, AIDS-Related Opportunistic Infections and CD4 Lymphocyte Count. Dr. Saadat has published most often in Clin Exp Dermatol. Dr. Saadat's most frequent co-authors are Manjunath S. Vadmal, MD, Ramin Ram, MD and Brittney Kaufman De Clerck, MD.

CMS Open Payments shows 1,241 general payments to Dr. Saadat from 49 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 36% of the total. Incyte Corporation paid the most, $70,195. It also lists 1 research payment totaling $200 in 2016.

Dmand AI lists 2 awards for Dr. Saadat.

Dr. Saadat graduated from Keck School of Medicine of USC in 2004.